OGN
Organon & Co.
NYSEUSDEQUITY
DELAYED
Last price
13.63
▼ 0.11 (0.80%)
MARKET · —
Price
Open
13.74
Prev close
13.74
Day high
13.76
Day low
13.73
Volume
1.49M
Market cap
—
P/E (TTM)
—
52W range
5.69 – 13.76
Trailing performance
Returnvs SPY
1W
+0.22%
+1.6%
1M
+1.40%
-2.3%
3M
+2.46%
-0.6%
6M
+69.75%
+58.7%
YTD
+91.77%
+79.5%
1Y
+46.74%
+26.7%
3Y
-39.85%
-114.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
13.70
-0.49% from price
SMA 20
13.63
+0.91% from price
SMA 50
13.54
+1.52% from price
SMA 100
12.50
+9.07% from price
SMA 200
9.96
+38.10% from price
EMA 12
13.68
-0.38% from price
EMA 26
13.61
+0.13% from price
EMA 50
13.35
+2.12% from price
RSI (14)
74.0
Overbought
MACD (12,26,9)
0.07
Hist 0.01
ATR (14)
0.04
0.32% of price
Realised vol 30D
2.8%
Annualised
Bollinger upper
13.78
20, 2σ
Bollinger lower
13.47
20, 2σ
50 / 200 cross
Golden
13.54 vs 9.96
Trend bias
Above 200
+38.10%
Risk profile
Beta vs SPY
0.70
Less volatile than market
Correlation to SPY
0.14
Largely independent
Realised vol 30D
2.8%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-48.2%
Peak to trough
Max drawdown 5Y
-85.5%
Peak to trough
ATR 14
0.04
0.32% of price
Beta (reported)
—
5Y monthly, from filing
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Priori Expands Client Advisory Board with New Members from Fortune 500 Corporate Legal Departments
GlobeNewswire · 9d ago
Organon Opens REMS Program for MIUDELLA® Ahead of Anticipated Commercial Availability
Business Wire · 11d ago
Compared to Estimates, Organon (OGN) Q2 Earnings: A Look at Key Metrics
Zacks · 22d ago
Organon (OGN) Lags Q2 Earnings Estimates
Zacks · 22d ago
Organon: Q2 Earnings Snapshot
Associated Press · 22d ago
Organon Announces Quarterly Dividend
Business Wire · 22d ago
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Zacks · 25d ago
Organon's Vtama Cream for Atopic Dermatitis Showed Improvement in Disease Severity in Clinical Study
MT Newswires · 29d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.